Microscopic examination of cultures of Escherichia coli exposed to bicyclomycin revealed elongated or spheroplast-like cells. At the lethal level, bicyclomycin was shown to inhibit the synthesis of RNA and protein in the growing cells of E. coli 15 THU, whereas DNA and lipid synthesis were not significantly affected. However, the antibiotic did not block RNA and protein synthesis in vitro.
from Daiichi Pharmaceutical Co., Ltd. Tetracycline hydrochloride was a product of Takeda Chemical Industries.
Thymine-2-14C (51 mCi/mmole), uracil-2-14C (21.0 mCi/mmole), L-arginine-14C (U) (175 mCi/ mmole), L-histidine-l-14C (10.48 mnCi/mmole), L-phenylalanine-14C (U) (382 mCi/mmole), acetate-1-14C (54.9 mCi/mmole), and L-leucine-14C (U) (251 mCi/mmole) were purchased from Daiichi Pure Chemicals Co., Ltd. L-Arginine-3H (G) (6.6 mCi/mmole) was a product of New England Nuclear Corp. Uridine-5'-triphosphate(UTP)-5, 6-3H (36.84 Ci/mmole) was purchased from Schwarz/Mann.
In vlvo macromolecular synthesis DNA, RNA and protein synthesis were followed by measuring the incorporation of labeled thymine, uracil and L-histidine into the acid-insoluble precipitates. At intervals after the addition of radioactive precursors, samples were removed to equal volumes of ice-cold 10 % trichloroacetic acid (TCA). After cooling for 30 minutes in an ice bath, the acid-insoluble precipitates were collected on a Millipore filter (0.45,u porocity) and washed with ice-cold 5% TCA. The radioactivity was counted in BRAY'S solution7) by a Packard Tri-Carb Liquid Scintillation Spectrometer.
In vivo lipid synthesis The synthesis of lipids was followed by measuring the incorporation of labeled acetate into the lipid fraction. Samples were removed at intervals and extracted with a mixture of chloroform-methanol (2 : 1), according to the procedure of NUNN8). The radioactivity was determined by dissolving the dried extract in toluene scintillation fluid containing 5 g of 2, 5-diphenyloxazole (PPO) and 0.3 g of 1, 4-bis-2(4-methyl-5-phenyloxazolyl)-benzene (dimethyl POPOP) per liter of toluene.
Preparation of cell-free extracts and S-30 fraction E. coli Q13 was grown in nutrient broth containing 5 % glucose, harvested by centrifugation, and stored in a frozen state. The cells were disrupted by grinding with alumina (Nakarai Chemical Co., Ltd.), and suspended in Tris buffer (10 mM, pH 7.0) containing 10 mm MgCl2, 0.1 mM EDTA and 10 mm 2-mercaptoethanol. The cellular debris was removed by centrifugation (20,000 g, 20 minutes). The S-30 fraction was prepared according to the procedure of NIRENBERG9) .
In vitro RNA and protein synthesis The RNA polymerase activity of cell-free extracts was assayed as described in the legend to Table 1 . Cell-free protein synthesis was followed by measuring the incorporation of labeled phenylalanine or labeled leucine into the hot TCA-insoluble material9).
Biosynthesis of envelope and cytoplasmic proteins Exponentially growing cultures were labeled with radioactive L-arginine for 2 minutes. The mixtures were immediately chilled in an ice bath and non-radioactive arginine was added. The cells were collected by centrifugation, washed with 10 mM sodium phosphate buffer (pH 7.1), and disrupted in the same buffer by treatment for 5 minutes with a sonic oscillator (20 kc) in an ice bath.
The envelope and cytoplasmic fractions were prepared by the differential centrifugation method as described by INOUYE and his co-workers10).
For envelope protein synthesis, the envelope fraction (pellet) was solubilized at 70°C for 20 minutes in an appropriate volume of the solubilizing solution (1 % sodium dodecyl sulfate (SDS), 10 % glycerol and 1%2-mercaptoethanol in 10 mm sodium phosphate buffer, pH 7.1). After solubilization, the solution was taken to measure the radioactivity incorporated into the envelope proteins, or was subjected to SDS-polyacrylamide gel electrophoresis.
For cytoplasmic protein synthesis, an equal volume of 10%TCA was added to the cytoplasmic fraction (supernatant). After cooling for 30 minutes in an ice bath, the mixtures were boiled for 30 minutes and chilled for 30 minutes in an ice bath. The hot acid-insoluble precipitates were collected on a membrane filter and washed with 5 % TCA. The radioactivity was counted in BRAY'S solution.
Lipoprotein synthesis in the histidine-starved cells of E. coli 15 THU The cells of E. coli 15 THU were grown in M9-glucose medium supplemented with thymine, histidine and uracil, washed and suspended in the above medium without histidine. Radioactive arginine was added to the suspension. After the incubation at 37°C, the mixtures were chilled in an ice bath. The cells were disrupted by sonic oscillation and the envelope fraction was prepared by centrifugation. Half of the envelope fraction was treated with egg white lysozyme (100 ug/ml) at 37°C for 3 hours in 10 mm sodium phosphate buffer, (pH 7.1) to analyze the bound form of the lipoprotein11). Lysozyme-treated and untreated fractions were then subjected to SDS-polyacrylamide gel electrophoresis; separate gels contained cytochrome c and Dansyl-insulin as markers. After electrophoresis, the position of lipoprotein was detected by reference to the cytochrome c and Dansyl-insulin and cut out.
After each slice was incubated with 0.5 ml of Soluene 350 (Packard) at 50°C for 3 hours, the radioactivity was counted in toluene scintillation fluid.
Preparation of peptidoglycan From the envelope fraction, the peptidoglycan was isolated using 4%SDS as described by BRAUN and SIEGLIN23). The insoluble precipitates in hot 4%SDS were collected by centrifugation at 105x,& for 60 minutes at 20°C, and washed twice with water before use.
SDS-polyacrylamide gel electrophoresis Polyacrylamide gels, 0.6 x 12 cm, were made with 7.5%acrylamide and 0.25 % methylenebisacrylamide as cross linking agent in the presence of ammonium persulfate and N, N, N', N'-tetramethylethylenediamine polymerized in 0.1 M sodium phosphate buffer, pH 7.1, containing 0.5%SDS.
Dansyl(5-dimethylaminonaphthalene-l-sulfonyl)-protein (DANS-protein) as internal moleculra standards were prepared by the method of INOUYE12). The procedure of WEBER13) was employed for staining of the gels.
Results

Morphological Changes in Bicyclomycin-treated Cells
The effect of treatment with bicyclomycin on the morphology of E. coli strains is shown in Plates 1 and 2. When the culture of E. coli 15 THU was exposed to bicyclomycin, elongated and spheroplast-like cells were observed under the microscope. The formation of elongated cells was induced at a level of 12.5 hg/ml of bicyclomycin (Plate 1 (B)). In the medium with 20%sucrose and 0.2%MgSO4 as a spheroplast stabilizer, the spheroplast-like cells were observed in the culture treated with a lethal concentration of 25 hg/ml of bicyclomycin (Plate 1 (C))
In the cells of E. coli ATCC 27166, which is a mutant hypersensitive to bicyclomycin, the majority of the cells were elongated many times their normal length at a level of 6 beg/ml of bicyclomycin (Plate 2 (B)). However, the FEULGEN-positive nuclear material in the elongated cells appeared to be uniformly distributed (Plate 2 (C)).
2. Effect of Bicyclomycin on the Synthesis of DNA, RNA and Protein in E. coli 15 THU Effects of bicyclomycin on DNA, RNA and protein synthesis are presented in Fig. 1 . The synthesis of DNA, RNA and protein in E. coli 15 THU were studied by following the incorporation of radioactive precursors. 14C-Thymine, 14C-uracil or 14C-L-histidine (0.5 uCi/ml, final concentration) was added to separate portions of the exponentially growing culture. Each portion was divided, and bicyclomycin (251eg/ml or 1001ug/ml, final concentration) was added to one part, the other serving as untreated control. The culture was incubated at 37°C. Samples were removed at intervals for determination of the radioactivity incorporated into the acid-insoluble material.
In the untreated control cultures, the synthesis of DNA, RNA and protein proceeded linearly for 60 minutes (Fig. 1 ).
In the cultures treated with bicyclomycin at 25 Etg/ml, which is approximately the minimal growth inhibitory concentration, the effects on RNA and protein synthesis during the first 30 minutes of incubation were not very evident .
In 60 minutes, however, some inhibition was In contrast, the culture exposed to bicyclomycin incorporated 14C-thymine into DNA at the same rate as the untreated control culture ( Fig. 1 (a) ). It indicated that bicyclomycin did not significantly affect DNA synthesis.
The Effect of Bicyclomycin of Lipid Synthesis
Radioactive acetate was added to the exponentially growing culture . It was divided, and bicyclomycin (100 pg/ml, final concentration) was added to one part , the other serving as untreated control. The mixtures were incubated at 37°C . Bicyclomycin (100 pg/ml) did not significantly affect the lipid synthesis.
The Effect of Bicyclomycin on in vitro RNA Synthesis
Since bicyclomycin was observed to inhibit RNA synthesis in vivo , the effect of bicyclomycin on RNA polymerase activity of the cell-free extracts was further examined .
As shown in Table 1 , bicyclomycin did not block the RNA polymerase activity of cell- The assay system contained 100 mumoles of ATP, GTP, CTP and UTP (3H-UTP, 0.5 pCi), 1.25 pmoles of magnesium acetate, 0.5 umole of MgSO4, 1.25 pmoles of 2-mercaptoethanol, 9 ug of herring sperm DNA, and 30 pmoles of Tris buffer (pH 7.8), and cell-free extracts in a total volume of 0.3 ml. The mixtures were incubated at 37°C and the radioactivity of TCA-insoluble material was counted in BRAY'S solution.
free extracts at the concentration of 6.25~1,000ig/(nl. The preincubation of bicyclomycin with template DNA showed no effect on the reaction. Bicyclomycin exhibited a slight stimulatory effect on RNA synthesis in vitro.
In contrast to bicyclomycin, the addition of 201ig/ml of rifampicin to the reaction mixture markedly inhibited the RNA polymerase activity by about 70% .
The Effect of Bicyclomycin on Cell-free Protein Synthesis
In order to elucidate the mechanism of bicyclomycin inhibition on protein synthesis in vivo, the effect of the antibiotic was examined with the cell-free extracts, synthesizing protein with endogenous mRNA or with poly (U)9).
Cell-free protein synthesis was not significantly affected by bicyclomycin over a wide range of concentrations (25~1,00012g/ml).
The Effect of Bicyclomycin on the Synthesis of Envelope and Cytoplasmic Proteins
Since protein synthesis in vitro was not significantly blocked by bicyclomycin, the effects on envelope and cytoplasmic protein synthesis were examined in order to elucidate the mechanism of the inhibition by the antibiotic of protein synthesis in viva.
Bicyclomycin (25pg/ml or 100 pg/ml, final concentration) was added to the exponentially growing cultures of E. coli 15 THU. The mixtures were incubated at 37°C for 5, 10 and 20 minutes, respectively, as shown in Fig. 2 .
After the incubation, each cultures was labeled with 14C-L-arginine (0.251iCi/ml, final concentration) for 2 minutes. The envelope and cytoplasmic fractions were prepared, and the incorporation of 14C-arginine into each fraction was measured as described in Materials and Methods.
As illustrated in Fig. 2 , the envelope protein synthesis was more sensitive to bicyclomycin than the cytoplasmic protein synthesis.
In the cultures treated with bicyclomycin at the level of 100 pg/ml, the differential inhibitory effect was observed. By 5, 10 and 20 minutes, the envelope protein 'synthesis was inhibited 35, 40 and 40%respectively, and the cytoplasmic protein synthesis was blocked 15% in each case ( Fig . 2 (a) ).
At a lower level of 25 pg/ml, the envelope protein synthesis was selectively inhibited 25% , whereas the cytoplasmic protein synthesis was not significantly affected ( Fig . 2 (b) ).
The Effect of Bicyclomycin on the Synthesis of Individual Envelope Protein
Bicyclomycin was observed to inhibit the envelope protein synthesis more selectively than the cytoplasmic protein synthesis (Fig. 2) . After the incubation, each culture was labeled with 14C-arginine (0.3 tiCi/ml) for 2 minutes.
The envelope and cytoplasmic fractions were prepared and these synthesis were measured as described in Materials and Methods.
The control experiment was carried out without the addition of bicyclomycin.
All data were expressed as rates of inhibition calculated as percentage of over-all incorporation of the control: (a) as a function of time in the presence of bicyclomycin (100 !yg/ml); (b) as a function of bicyclomycin concentration for 5 min-incubation. was prepared, and the envelope proteins were then separated by SDS-polyacrylamide gel electrophoresis. The gel patterns of the envelope proteins labeled in the presence of two different concentrations of the antibiotic, where presented in Fig. 3 . Four major peaks appeared without addition of bicyclomycin, and they were numbered as shown in Figs. 3 and 4 .
The biosynthesis of peak II and V proteins was more sensitive to bicyclomycin than that of the other envelope proteins. In the presence of 25 pg/ml of the antibiotic, the incorporation of 14C-arginine into peaks II and V was inhibited 44 % and 48 %, respectively. Similarly, in the presence of 100 pg/ml of the antibiotic, the biosynthesis of peak II and V proteins was inhibited 50%and 56%. The inhibition of synthesis of the individual proteins by bicyclomycin is summarized in Table 2 .
As illustrated in Fig. 4 , the peak V protein was located between cytochrome c and Dansyl-insulin and did not contain L-histidine, as shown by the double label experiment. Thus, the protein at peak V was considered to be identical with the free form of the lipoprotein reported by INOUYE and his co-workers14).
Plate 3 presents the results when the envelope fractions in the bicyclomycin (100 pg/ml)-treated culture were compared with those in normal culture by SDS-polyacrylamide gel electrophoresis. The band at the position of the lipoprotein was scarcely detected with the antibiotic-treated cells.
These results suggest the selective inhibition by bicyclomycin of the biosynthesis of lipoprotein. After the treatment with bicyclomycin for 5 minutes, the culture of E. coli 15 THU was labeled with 14C-arginine as shown in Fig. 2 . The envelope fraction was prepared and subjected to SDS-polyacrylamide gel electrophoresis.
For each gel pattern as shown in Fig. 3 , the total radioactivities of peak II, III, IV and V were measured, respectively. The rate of inhibition of each peak fraction was calculated as percentage of the over-all incorporation of control.
Fig. 4. Gel electrophoresis of the envelope proteins of E. coli 15 THU double-labeled with 3H-L-arginine and 14C-L-histidine
The envelope fraction was prepared and subjected to SDS polyacrylamide gel electrophoresis. After electrophoresis. the gels were sliced with a razor, and the radioactivity of each slice was counted as described in Materials and Methods. Assignments of internal standards are the same as in Fig. 3 the lipoprotein, which does not contain histidine, can be synthesized normally, even when the histidine auxotroph of E. coli is starved for histidine. Under this condition, the biosynthesis of all the other envelope proteins is almost completely blocked. Since bicyclomycin inhibited selectively the lipoprotein synthesis , the effect of the antibiotic was examined on the exclusive biosynthesis of lipoprotein of E . coli 15 THU in the absence of histidine.
14C-L -Arginine (0 .3,uCi/ml, final concentration) and bicyclomycin were added to the cell suspension in the absence of histidine, and the mixtures were incubated at 37°C for 90 minutes . The cytoplasmic and envelope fractions were prepared, and the envelope fraction was subjected to SDS-polyacrylamide gel electrophoresis. As shown in Fig. 5 , the peak I (origin) and V (lipoprotein) appeared but the other peaks had disappeared. 14C-Arginine was incorporated into the cytoplasmic and envelope proteins, and 30~40 % of the radioactivity incorporated into envelope proteins was that of the free form of lipoprotein.
In the cells exposed to bicyclomycin over a wide range of concentrations , the envelope protein synthesis was inhibited 33 %, whereas the cytoplasmic protein synthesis was scarcely affected (Table 3) .
Plate 3. Effects of bicvclomvcin on the synthesis of envelope proteins Bicyclomycin (100 ,,g/ml. final concentration) was added to the exponentially growing cultures of E. coli 15 THU. The mixtures were incubated at 30°C for 60 minutes. The control experiment was carried out without the addition of bicyclomycin. The envelope fractions were prepared and subjected to SDS-polyacrylamide gel electrophoresis.
After electrophoresis, the gels were stained by the procedure of WEBER13).
(A) Internal molecular weight standards; a, DANS-serum albumin; b, DANS-trypsin; c, cytochrome c; e, DANS-insulin (B) Control; d, the free form of lipoprotein (C) Bicyclomycin, 100 eg/m 1
Bicyclomycin and 14C-arginine were added to the cultures starved for histidine. The mixtures were incubated at 37°C for 90 minutes. The control experiment was carried out without the addition of biocyclomycin. After the incubation, the envelope fractions were prepared as described in Materials and Methods, and subjected to SDS-polyacrylamide gel electrophoresis. After electrophoresis, the portions of the gel at the peaks I and V determined by standard markers were sliced with a razor, and then the radioactivity of each slice was counted as described in Materials and Methods.
All data were expressed as rates of inhibition calculated as percentage of the over-all incorporation of controls.
As shown in Table 3 , inhibitory effects of bicyclomycin on the biosynthesis of the lipoprotein (peak V) and the peak I protein were observed. The incorporation of 14C-arginine into the lipoprotein was inhibited 52~60 %. The incorporation into the peak I protein, even at a low level of 25 µg/ml, was inhibited 88 %.
Although the strong inhibition of peak I protein was constantly observed, the grade of inhibition of peak V protein varied in the range of 10 % to 60 % (Tables 3, 4, 5 and Figs. 5, 6 ).
The Effect of Bicyclomycin on the Biosynthesis of the Bound Form of Lipoprotein
The results in Table 3 indicate that the primary action of bicyclomycin may be due to the inhibition of the peak I protein synthesis. INOUYE and his co-workers11) have reported that most of proteins at the origin in SDS-polyacrylamide gel electrophoresis are the bound form of the lipoprotein linked to the peptidoglycan. Therefore, the amount of the bound form of lipoprotein was expressed as the difference of radioactivity at peak I between the lysozvmetreated and untreated envelope fractions.
The effect of bicyclomycin was examined on the biosynthesis of the bound form of lipoprotein, and compared with that of other antibiotics. 3H-L-Arginine (0.25 µCi/ml, final concentration) and the antibiotic were added to the cell suspension of E. coli 15 THU in the absence of histidine, and the mixtures were incubated at 37°C for 45 minutes. As presented in Table 4 , in the bicyclomycin-treated cells, the envelope protein synthesis was inhibited 20 %, but the cytoplasmic protein synthesis was not significantly affected. The gel patterns of the envelope fraction in the presence or absence of bicyclomycin were shown in Fig. 5 . Bicyclomycin inhibited the synthesis of the peak I protein 80 % and that of the free form of lipoprotein only 14 %.
A half of the envelope fractions was treated with lysozyme and subjected to SDS-polyacrylamide gel electrophoresis. Without addition of the antibiotics, 90 % of the 3H radioactivity, which stayed on top of the gel before the lysozyme treatment, disappeared and shifted to near the position of the free form of the lipoprotein after the lysozyme treatment. Thus, most of the peak I protein were due to the bound form of lipoprotein. In the bicyclomycin-treated cells, in which synthesis of peak I was inhibited more than 80 go , the radioactivity of the peak I protein was scarcely transferred from top of the gel by the lysozyme treatment.
The biosynthesis of the bound form of lipoprotein was blocked almost completely (91 %) by bicyclomycin (Table 4) . Thus, the biosynthesis of the bound form of lipoprotein was more sensitive to inhibitory action of bicyclomycin than that of the free form of lipo- Table 4 , rifampicin inhibited synthesis of the free form of lipoprotein by only 27 %, and the peak I protein (the bound form) synthesis only 26%. However, concurrent treatment with both bicyclomycin and rifampicin exhibited additive inhibition of the synthesis of the free form of lipoprotein, whereas synthesis of the peak I The experiments were carried out as described in the legend to Table 4 . The envelope fractions were subjected to SDS polyacrylamide gel electrophoresis.
Assignments of internal standards are the same as in Fig. 4 . The number indicates each peak. The inhibition of formation of these proteins by bicyclomycin is shown in Fig. 6 .
Synthesis of the envelope proteins was inhibited by 50 %, whereas that of the cytoplasmic proteins was not significantly affected.
As for the lipoprotein, synthesis of the free form and the bound form were blocked approximately 60 % and 95 %, respectively.
For the purpose of confirming the inhibitory effect of bicyclomycin on the biosynthesis of the bound form, the peptidoglycan was prepared using 4 % SDS, treated with lysozyme and analyzed by SDS-polyacrylamide gel electrophoresis to determine the amount of the bound form Bicyclomycin and 14C-L-arginine were added to the culture starved for histidine. The mixtures were incubated at 37°C for 15, 30 and 45 minutes. The envelope fraction was prepared, and half of it was treated with lysozyme. Each fraction was subjected to SDS polyacrylamide gel electrophoresis. All data were expressed as rates of inhibition calculated as percentage of the over-all incorporation of controls. The effects of bicyclomycin on the biosynthesis of the bound form of lipoprotein were observed by isolating the peptidoglycan, which was then treated with lysozyme ( Table 5 ). The biosynthesis of the bound form was inhibited by 80 o. The grade of inhibition was in accordance with that of the peak I protein.
In contrast, the synthesis of the free form was inhibited only 10 '00".
The above results indicated that bicyclomycin is a potent inhibitor of the biosynthesis of the bound form of lipoprotein.
Discussion
The results suggest that the primary action of bicyclomycin is due to interference with the biosynthesis of lipoprotein and its assembly to peptidoglycan in the cell envelope of E. coli.
The lipoprotein has been reported to exist in two forms11,14) in the outer membrane of E. coli: i.e. the free form, and the bound form which is covalently bound on average to every 10~12 diaminopimelate residues of peptidoglycan by the C-terminal lysine4). About 7.5× 105 molecules of lipoprotein are assumed to be present in a cell. Thus, it is considered to be the most abundant protein and have an important function in stabilizing the total structure of the cell wall4.5,21). The mechanism of biosynthesis and assembly of the lipoprotein has also been investigated. The free form of lipoprotein is first synthesized on the ribosomes directed by mRNA specific for the lipoprotein and converted into the bound form attached to peptidoglycan10, 11, 14, 15, 16, 17) Although the variation (10~60 %) in inhibition is observed as shown in Tables 3, 4 and 5, it is certain that the synthesis of the free form of lipoprotein is sensitive to bicyclomycin. The free form of lipoprotein synthesized in the presence of bicyclomycin may be incomplete and lacking in the capacity of binding with peptidoglycan. The marked inhibition of synthesis of the bound form may probably be a secondary effect caused by the disturbance of the free form synthesis.
From the viewpoint of the mechanism of the lipoprotein synthesis14), the alternative explanation is that the primary action of bicyclomycin may be the inhibition of the conversion of the free form to the bound form. Tables 4 and 5 show the characteristics of action of bicyclomycin in comparison with that of rifampicin.
The conversion of the free form to the bound form has been shown to be independent upon protein synthesis and the energy production14). INOUYE and his co-workers suggest14) that the reaction is caused by transpeptidase in a similar way to the formation of cross-linkages between two peptide units of peptidoglycan, and the covalent linkage between the s-amino group of the C-terminal lysine of the lipoprotein and the carboxy group of diaminopimelic acid in the peptidoglycan may be formed by releasing D-alanine or D-alanyl-D-alanine from the peptide unit of peptidoglycan. IZAKI and STROMINGER18) have described carboxypeptidase II, which releases the second D-alanine residue from the peptide unit of peptidoglycan.
It seems to be of interest to examine the effect of bicyclomycin on the release of D-alaninc by carboxypeptidase II in the presence of the free form of lipoprotein.
